Tomomi Tsuru
Overview
Explore the profile of Tomomi Tsuru including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
245
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fukui S, Michitsuji T, Endo Y, Nishino A, Furukawa K, Morimoto S, et al.
RMD Open
. 2025 Jan;
11(1).
PMID: 39863304
Objectives: To evaluate the potential of clinical factors, ultrasound findings, serum autoantibodies, and serum cytokine and chemokine profiles as predictors of clinical outcomes in rheumatoid arthritis (RA). Patients And Methods:...
2.
Akasaki Y, Yamada H, Kondo M, Fukushi J, Sakuraba K, Miyamura T, et al.
Clin Exp Rheumatol
. 2025 Jan;
PMID: 39808284
Objectives: The purpose of the present study was to investigate the differential impact of disease activity and severity on functional status and patient satisfaction in rheumatoid arthritis (RA) using cluster...
3.
Maeyama A, Kondo M, Harada H, Shono E, Nagamine R, Tsuru T, et al.
BMC Rheumatol
. 2024 Dec;
8(1):69.
PMID: 39695823
Background: This study aimed to compare the efficacy and safety of baricitinib in patients with rheumatoid arthritis (RA) receiving different doses based on renal function. Methods: We conducted a retrospective...
4.
Ayano M, Ueda N, Mishima K, Ota S, Kushimoto K, Tanaka A, et al.
Mod Rheumatol
. 2024 Aug;
35(1):102-109.
PMID: 39096517
Objectives: This study aimed to describe the treatment selection for systemic lupus erythematosus (SLE) using data from the Kyushu Collagen Disease Network for SLE (KCDN-SLE) registry, a multicentre prospective registry...
5.
Kawahara C, Fukui S, Michitsuji T, Nishino A, Endo Y, Shimizu T, et al.
Mod Rheumatol
. 2024 May;
34(6):1142-1148.
PMID: 38756078
Objectives: We aimed to evaluate the effects of age on clinical characteristics and outcomes in biologic or targeted synthetic disease-modifying antirheumatic drug (b/tsDMARD)-naïve patients with rheumatoid arthritis (RA). Methods: We...
6.
Harada H, Kondo M, Maeyama A, Fukuda T, Ikemura S, Shono E, et al.
Clin Rheumatol
. 2024 Mar;
43(5):1787-1791.
PMID: 38489137
No abstract available.
7.
Nonaka F, Fukui S, Michitsuji T, Endo Y, Nishino A, Shimizu T, et al.
Int J Rheum Dis
. 2024 Mar;
27(3):e15118.
PMID: 38487995
Objective: Glucocorticoids are effective in treating rheumatoid arthritis (RA) when used appropriately considering the balance of the risks and benefits, especially at low doses. We aimed to evaluate the response...
8.
Harada H, Kondo M, Maeyama A, Fukuda T, Ikemura S, Shono E, et al.
Clin Rheumatol
. 2024 Jan;
43(5):1447-1459.
PMID: 38182801
Objective: The efficacy and safety of sarilumab (SARI) were investigated in real-world clinical practice in Japan. Method: Subjects were 121 rheumatoid arthritis (RA) patients in 23 medical institutions in Fukuoka...
9.
Yamada H, Haraguchi A, Tsuru T, Kondo M, Sagawa F, Niiro H, et al.
Ann Rheum Dis
. 2023 Jul;
82(12):1637-1638.
PMID: 37433576
No abstract available.
10.
Kashiwado Y, Kiyohara C, Kimoto Y, Nagano S, Sawabe T, Oryoji K, et al.
Arthritis Res Ther
. 2022 Jun;
24(1):131.
PMID: 35650638
Background: To analyse the subsequent clinical course of patients with rheumatoid arthritis (RA) who either continued or discontinued biologic agents after hospitalization for infections. Methods: We retrospectively reviewed the clinical...